627076-27-1

Basic information

• Product Name: 1-(2-(trifluoromethyl)benzyl)hydrazine
• Synonyms: 1-(2-(trifluoromethyl)benzyl)hydrazine;{[2-(Trifluoromethyl)phenyl]methyl}hydrazine
• CAS NO: 627076-27-1
• Molecular Formula: C₈H₉F₃N₂
• Molecular Weight: 190.17
• Mol File: 627076-27-1.mol

Chemical Properties

• Boiling Point: 254.4±40.0 °C(Predicted)
• Appearance: /
• Density: 1.253±0.06 g/cm3(Predicted)
• PKA: 6.85±0.10(Predicted)
• CAS DataBase Reference: 1-(2-(trifluoromethyl)benzyl)hydrazine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-(trifluoromethyl)benzyl)hydrazine(627076-27-1)
• EPA Substance Registry System: 1-(2-(trifluoromethyl)benzyl)hydrazine(627076-27-1)

Safety Data

• Hazardous Substances Data: 627076-27-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-(2-(trifluoromethyl)benzyl)hydrazine is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical field, 1-(2-(trifluoromethyl)benzyl)hydrazine serves as a precursor for the creation of novel agrochemicals, contributing to the development of more effective and targeted pest control solutions.
Used in Coordination Chemistry:
As a ligand in coordination chemistry, 1-(2-(trifluoromethyl)benzyl)hydrazine is utilized for the formation of coordination complexes. These complexes have potential applications in various areas, such as catalysis and materials science.
Used in Cancer Research:
1-(2-(trifluoromethyl)benzyl)hydrazine has been studied for its potential as an anticancer agent. Its unique properties may contribute to the development of new therapeutic strategies against various types of cancer.
Used in Organic Chemistry Research:
Due to its versatile structure, 1-(2-(trifluoromethyl)benzyl)hydrazine is a valuable compound for research in organic chemistry. It can be used to explore new synthetic pathways and develop innovative chemical reactions.

Relevant articles and documents

ADENOSINE A2A RECEPTOR ANTAGONISTS

Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein: X1 and X2 are 1-3 substituents independently selected from the group consisting of H, alkyl, halo, —CF3, —OCF3, alkoxy, —OH and —CN;n is 0, 1 or 2; andR and R1 are H or alkyl; also disclosed is the use of the compounds in the treatment of CNS diseases such as Parkinson's disease, alone or in combination with other agents for treating CNS diseases, pharmaceutical compositions comprising them and kits comprising the components of the combinations.